YY1-Induced lncRNA PART1 Enhanced Resistance of Ovarian Cancer Cells to Cisplatin by Regulating miR-512-3p/CHRAC1 Axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

YY1-Induced lncRNA PART1 Enhanced Resistance of Ovarian Cancer Cells to Cisplatin by Regulating miR-512-3p/CHRAC1 Axis

Published:2021-06-01 Issue:6 Volume:40 Page:821-832
ISSN:1044-5498
Container-title:DNA and Cell Biology
language:en
Short-container-title:DNA and Cell Biology

Author:

Yang Hongbo¹,Zhang Xuegang²,Zhu Li³,Yang Yang³,Yin Xinming³^ORCID

Affiliation:

1. Department of Gynecology, Huai'an Maternity and Child Care Hospital, Huai'an, Jiangsu, China.

2. Department of Gynecology, the First People's Hospital of Kunshan, Suzhou, Jiangsu, China.

3. Department of Gynecology, the Fourth Affiliated Hospital of Jiangsu University, Zhenjiang, China.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Genetics,Molecular Biology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/dna.2021.0059

Reference41 articles.

1. Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway

2. Noncoding RNA:RNA Regulatory Networks in Cancer

3. Inhibition of c-FLIP expression by miR-512-3p contributes to Taxol-induced apoptosis in hepatocellular carcinoma cells

4. Long non-coding RNAs in anti-cancer drug resistance

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CircFAM188A Regulates Autophagy via miR‐670‐3p and ULK1 in Epithelial Ovarian Carcinoma;Cancer Reports;2024-09

2. HDAC9 and miR-512 Regulate CAGE-Promoted Anti-Cancer Drug Resistance and Cellular Proliferation;Current Issues in Molecular Biology;2024-05-24

3. LncRNA HCG18 promotes prostate cancer progression by regulating miR-512-3p/HK-2 axis;Asian Journal of Urology;2024-02

4. Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer;PeerJ;2024-01-10

5. Therapeutic potential of miRNAs in placental extracellular vesicles in ovarian and endometrial cancer;Human Cell;2023-10-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3